These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10069460)

  • 1. Characterization of cytochrome P450 expression in human oesophageal mucosa.
    Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
    Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
    Sarikaya D; Bilgen C; Kamataki T; Topcu Z
    Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.
    Godoy W; Albano RM; Moraes EG; Pinho PR; Nunes RA; Saito EH; Higa C; Filho IM; Kruel CD; Schirmer CC; Gurski R; Lang MA; Pinto LF
    Carcinogenesis; 2002 Apr; 23(4):611-6. PubMed ID: 11960914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.
    Pinto LF; Moraes E; Albano RM; Silva MC; Godoy W; Glisovic T; Lang MA
    Carcinogenesis; 2001 Nov; 22(11):1877-83. PubMed ID: 11698352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
    Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
    Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine.
    Gopalakrishnan R; Morse MA; Lu J; Weghorst CM; Sabourin CL; Stoner GD; Murphy SE
    Carcinogenesis; 1999 May; 20(5):885-91. PubMed ID: 10334207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples.
    Baker JR; Satarug S; Reilly PE; Edwards RJ; Ariyoshi N; Kamataki T; Moore MR; Williams DJ
    Biochem Pharmacol; 2001 Sep; 62(6):713-21. PubMed ID: 11551516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments.
    Roos PH; Belik R; Föllmann W; Degen GH; Knopf HJ; Bolt HM; Golka K
    Arch Toxicol; 2006 Jan; 80(1):45-52. PubMed ID: 16341845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
    Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of cytochrome p-450 2a3 in N-nitrosomethylbenzylamine metabolism in rat esophagus.
    Gopalakrishnan R; Gupta A; Carlton PS; Morse MA; Stoner GD
    J Toxicol Environ Health A; 2002 Aug; 65(15):1077-91. PubMed ID: 12167220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells.
    Crawford EL; Weaver DA; DeMuth JP; Jackson CM; Khuder SA; Frampton MW; Utell MJ; Thilly WG; Willey JC
    Carcinogenesis; 1998 Oct; 19(10):1867-71. PubMed ID: 9806171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.
    Hughes SJ; Morse MA; Weghorst CM; Kim H; Watkins PB; Guengerich FP; Orringer MB; Beer DG
    Neoplasia; 1999 Jun; 1(2):145-53. PubMed ID: 10933049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.
    Macé K; Bowman ED; Vautravers P; Shields PG; Harris CC; Pfeifer AM
    Eur J Cancer; 1998 May; 34(6):914-20. PubMed ID: 9797707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
    Bergheim I; Bode C; Parlesak A
    BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.
    Molina-Ortiz D; Camacho-Carranza R; González-Zamora JF; Shalkow-Kalincovstein J; Cárdenas-Cardós R; Ností-Palacios R; Vences-Mejía A
    PLoS One; 2014; 9(4):e93261. PubMed ID: 24699256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal cytochrome P450 2A: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen.
    Thornton-Manning JR; Nikula KJ; Hotchkiss JA; Avila KJ; Rohrbacher KD; Ding X; Dahl AR
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):22-30. PubMed ID: 9007030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.